Meta-analysis of 4 RCTs in sepsis or COVID-19 with lymphopenia: rhIL-7 increased lymphocyte counts (MD 1.15 at 3 weeks) and reduced secondary infections (RR 0.64) but had no effect on mortality or ICU length of stay.
Meta-analysisn = 4 trials
Lu et al. Recombinant human interleukin-7 for patients with infection-associated lymphopenia: a systematic review and meta-analysis